Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Clinical trial NCT01314833 · COMPLETED
Trial details
- NCT number
- NCT01314833
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 1570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.